register

Market Research & Insights

Top concern and key challenges for Australian healthcare and pharma leaders

Health Industry Hub | August 28, 2019 |

A recent PwC report revealed rising costs and their ensuing pressures on key stakeholders as the top concern of healthcare and pharma leaders. At the same time, more than 80% of healthcare and pharma organisations are doing more with fewer resources.

So what is required to lean into these concerns? What expertise and added value can the relevant service providers and suppliers offer to support the industry?

Key challenges in Australia, according to PwC report

Challenge 1: Turning inward to reduce the talent gap

Leaders see concerns around the availability of key internal skills. Many businesses are having to reflect on how to attract, train and retain their workforce. People costs are rising more than expected as a result, so is it time to think differently about ways to solve their skills challenge?

Challenge 2: Mountains of data, molehills of intelligence

Leaders are working to bridge the gap of translating a deluge of data into better decision making. Only 7% believe their customer data is comprehensive and finding the right data talent is a significant challenge.

Challenge 3: AI at the tipping point

Artificial Intelligence (AI) has the potential to supercharge growth, but without clean, relevant, and labeled data – and the workforce to harness this – organisations are being hindered in their efforts to move aggressively on AI.

What do you think? Share your views to help the Pharma, MedTech and Biotech industries.

With more than 80% of healthcare and pharma organisations doing more with fewer resources, how is superior value delivered by the top service providers and suppliers to support you in your role in Pharma, Biotech or MedTech? What gaps can be addressed to better assist you?

Help the Pharma, MedTech and Biotech industries by sharing your input in this anonymous 2 minutes survey. You may click here to take the survey or alternately scroll down this page to share your views.

You may opt in to receive the aggregated results at the end of the survey.

Create your own user feedback survey

News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.